Honored that Our Consensus Paper on MIBC Receives June 2026 EU Impact Award / Alberto Briganti, Andrea Necchi, Arlene O.

New Approach to Individualizing Treatment Selection in Myelofibrosis / Anthony M. Hunter, cancer, myelofibrosis, OncoDaily, ...

Hope, Hype, and What the Evidence Really Shows / Alternative Cancer Treatments, Antiparasitic Drugs, cancer drugs, cancer ...

The Women in the Roots of Oncology / American Society of Clinical Oncology, ASCO, cancer, Jane Cooke Wright, Matuschka, ...

BioNTech Terminates Phase 2 Autogene Cevumeran mRNA Cancer Vaccine Trial in Colorectal Cancer / BioNTech, BNT122-01, ...

Genentech Secures Major DualityBio ADC Deal With US$45 Million Upfront / ADC Payloads, ADC resistance, Antibody drug ...

Real-world data from 2,662 patients show endocrine exhaustion, rising chemotherapy use and shorter PFS in HR-positive, ...

ASCO 2026 reshapes driver-positive stage IV NSCLC with EGFR intensification, sunvozertinib, and major ALK, ROS1 and HER2 ...

Highlights From Community Oncology Global Congress 2026, Day 2 / Abena Yeboah Aduse-Poku, Adedayo Joseph, Arturo ...

Alan Palkowitz on How IBRI Is Bridging the Gap Between Scientific Discovery and Patient Impact / Alan Palkowitz, biomedical ...

The NCI–NIAAA Population Approaches to Reducing Alcohol-Related Cancer Risk R01 Grant supports interdisciplinary research ...

Too Many Faces, Too Many Kids - Why DIPG Research Matters / cancer, Childhood Cancer, Dean Crowe, diffuse intrinsic pontine ...